Related by context. All words. (Click for frequent words.) 78 regulatory approvals 73 regulatory approval 67 necessary regulatory approvals 66 requisite regulatory approvals 66 stockholder approvals 65 applicable regulatory approvals 65 antitrust clearance 64 shareholder approvals 64 customary regulatory approvals 62 requisite approvals 60 governmental approvals 59 stockholder approval 58 customary closing conditions 57 approvals 56 Pending regulatory approvals 56 customary closing 55 consents authorizations 53 lender consents 53 requisite stockholder 52 Hart Scott Rodino 52 statutory clearances 52 approval 51 FIPB approval 51 FIRB approval 51 USFDA approval 50 HSR clearance 50 regulatory authorizations 50 obtaining regulatory approvals 49 successfully commercialize Iluvien 49 Antitrust Improvements Act 48 Allovectin 7 r 48 Antitrust Improvement 48 HSR Act 48 market PolyHeme commercially 47 please visit www.innercool.com 47 securityholder approval 47 Metabasis stockholders 47 requisite consents 47 Gestiva TM 47 unitholder approval 46 satisfactory due diligence 46 FIPB nod 46 MethyPatch 46 SFDA approval 46 Yahoo capitulates 46 definitive documentation 46 disinterested shareholder 46 Acquisition Transaction 46 Regulatory Approvals 45 Rotarix R 45 promote ceftobiprole 45 Orphan Drug designation 45 PerClot 45 Mutual Recognition Procedure 45 DC Bead 45 Final Offer Documents 45 Orphan Drug Status 45 transfusional iron overload 45 GLASSIA ™ 45 c SIGA 45 Shareholder Approval 45 definitive agreements 45 viii inability 44 HSR Antitrust Improvements 44 Aeroflex stockholders 44 Regulatory Approval 44 Requisite Consents 44 commercialize telaprevir 44 Medicis Inamed 44 Orphan Drug status 44 Proposed Transactions 44 Xenith Corporation 44 valid acceptances 44 Synerx 44 Visian Toric ICL 44 ComfortScan system 44 Biologic License Application BLA 44 Consummation 44 successfully commercialize Silenor 44 risks anduncertainties 44 KIF6 Genotyping Assay 43 Tendering holders 43 Hanlong transaction 43 CLIA certification 43 thetransaction 43 Marketing Authorisation 43 Fast Track designations 43 Methylphenidate Transdermal System 43 Nabi HB Intravenous 43 Zila stockholders 43 FIPB clearance 43 confirmatory due diligence 43 WDEQ Permit 43 SynthRx 43 Cellu Tissue stockholders 43 Marketing Authorizations 43 blood thinner rivaroxaban 43 vinorelbine emulsion 43 Sanex brand 43 Tostrex 43 rapid prototyping patents 43 Consent Fees 43 Biologics License Application 43 ISO Certification 43 ANDA submission 43 authorizations 43 NitroMed BiDil 43 CoStar stent 43 otherfactors 43 orally bioavailable compound 42 Mago ® 42 Offer Period 42 CLIA waiver 42 JOULFERON 42 Campto 42 securityholder approvals 42 TP# CETi 1 42 Qinnan PSC 42 Marketing Authorization Applications 42 PharMerica LTC Transaction 42 Asentar TM 42 EDQM 42 RSPO certification 42 CORLUX CORT # 42 TriPath Oncology 42 marketed GeoVax raises 42 Trubion stockholders 42 Goldcorp Andean 42 cytokine immunomodulator 42 BiDil XR drug 42 UASL license 42 Civacir 42 clearance 42 Mediaseed R 42 NSE SUNPHARMA 42 regulatory 42 CIP TRAMADOL ER 42 Early Settlement Date 42 HACCP certification 42 transgenically produced product 42 navratna status 42 successfully commercialized 42 Financing Condition 42 Marketing Authorization 42 Premarket Approval 42 Juanicipio whereby 42 Evoltra ® 42 ISO #:# Certification [001] 42 synergies therefrom 42 PentaStaph 42 suspensive conditions 42 Increlex TM 41 self affirmed GRAS 41 statements arebased 41 risksand uncertainties 41 OIO approval 41 STRIANT ® 41 No Objection Letter 41 PVC Additives 41 eprodisate KIACTA TM 41 Loramyc 41 & Workover Fluids 41 Lebowa transaction 41 Zevtera 41 AnGes 41 ISO certifications 41 Marketing Authorisation Application 41 Makes Hostile 41 HSR Waiting Period 41 Safe Harbors created 41 ORTHOVISC mini 41 Glassia 41 commercialize BiDil 41 Merial Intervet 41 Investigational Device Exemption 41 requisite clearances 41 Sangaredi Refinery Project 41 BLA filing 41 Monovisc 41 SEBIVO 41 #L Sterilizer 41 ANDA approvals 41 Nasdaq IMDC 41 Orosi Mill project 41 iQuran offer 41 FCC PTCRB 41 Somatuline Autogel 41 AzaSite Plus 41 Neurogen stockholders 41 d SIGA 41 ATryn ® 41 Somaxon ability 41 ISO #:# certification [001] 41 commercialize StaphVAX 41 Proposed Transaction 41 mutually acceptable definitive 41 GCF certification 41 shares issuable pursuant 41 Marketing Authorization Application 41 Approval 41 SurModics Pharmaceuticals 41 ventures Validus 41 CONBRIZA 41 Cremation rites 41 CE Marked 41 Provet Holdings 41 thecompletion 41 Market Approval PMA 41 consummating acquisitions 41 successfully integrate 41 ELEVESS 41 OMP designation 41 EGRIFTA TM 41 ruxolitinib 41 definitive agreement 41 Rheoscience 41 Loramyc ™ 41 Shigamabs 41 LOI contemplates 41 CE Marking 41 Promus Element stent 41 DYNACIN R Tablets 41 Rhein Biotech NV 41 GMP certification 41 Vitaros 41 MedMira rapid 41 Merger Transactions 41 Schering Plough Kenilworth NJ 41 clearances 41 Cellegesic 41 EASA certification 41 sumatriptan DosePro 40 Zenpep 40 Eutronsec 40 premerger notification 40 Proposed Takeover 40 bookbuilding process 40 ZADAXIN ® 40 Shire BioChem Inc. 40 Travelers Diarrhea vaccine 40 forodesine HCl 40 render PolyHeme obsolete 40 hyperimmune products 40 Certificate STC 40 Announces Tentative Approval 40 refusal ROFR 40 CanElson 40 Common Criteria certifications 40 legally enforceable undertakings 40 Solfotara Mining Corporation 40 Type Inbox 40 Operator Certificate AOC 40 WHO prequalification 40 divestures 40 GRAS determination 40 OTCBB BTEM 40 involve risks anduncertainties 40 Rozetta Cell 40 Guidant stent 40 Announce Shareholder Approval 40 Evithrom 40 known teratogen substance 40 OMAPRO ™ 40 Zolpidem Tartrate Tablets 40 SNY SAN.FR 40 TRISENOX ® 40 PROMACTA ® 40 Ceragenin ™ technology 40 Biological License Application 40 Cordis steerable guidewires 40 ZALBIN 40 Somatuline R Autogel R 40 BugOil R 40 Common Criteria evaluation 40 GVAX Immunotherapies 40 GLP toxicology studies 40 Voraxaze 40 CDP# 40 Lumera stockholders 40 Glaxo Cervarix 40 GEM #S 40 scissor lift serviced 40 Application MAA 40 Proposed Acquisition 40 Impax ANDA 40 GRAS notification 40 Loramyc TM 40 BLA submission 40 divestitures 40 Fortesta 40 Conditional Approval 40 Contrave NDA 40 miconazole MBT 40 valtorcitabine 40 telavancin NDA 40 regarding Heska 40 tivozanib AV 40 PTCRB certification 40 soliciting proxies 40 risks associatedwith 40 PMA submission 40 Plenaxis R 40 ISO #:# certifications [002] 40 successfully commercialize 40 mutually satisfactory definitive 40 GTC recombinant human 40 Oncosphere 40 Ondansetron Injection 40 Release Capsules 40 redomiciliation 40 Ceragenin TM technology 40 Applications ANDA 40 subsidiary Glenmark Generics 40 Vascular Wrap TM 40 Approvable Letter 40 Vele coking coal 40 Fluviral 40 generic Lipitor 40 authority NMa 40 CS.L Quote Profile Research 40 naronapride 40 BRILINTA 40 Power3 patent 40 received CE Conformite 40 without limitation Terremark 40 results performance orachievements 40 Preotact R 40 Scheme Document 40 repopulate CNS 40 sirtuin modulators 40 Allovectin 7 R 40 FIPS certification 40 Troxatyl TM 40 Trobalt 40 Proposed Qualifying Transaction 40 LoI 40 Zensana 40 consummation 40 AMID Stapler ™ 39 InCentive Capital AG 39 generic atorvastatin 39 NESINA 39 Common Criteria certification 39 subsidiary Venturbay Consultants 39 Smithway 39 IOSA registration 39 SuperStitch ® 39 Proposed Combination 39 Inc. NYSE MYL 39 wagering ceasing 39 Novartis AG NOVN.VX 39 BioOne Corporation 39 Expiration Time 39 Fast Track designation 39 USFDA nod 39 Synvisc ONE 39 iii Cubist 39 Board FIPB 39 Hejia Software 39 antitrust regulators 39 rThrombin 39 Metformin GR 39 specify Kirrin News 39 airworthiness certification 39 Board Unanimously Rejects 39 documentation evidencing 39 OTC ZEGERID 39 NASDAQ CHIP VeriChip 39 acceptances 39 Fampridine SR Acorda Therapeutics 39 Nycomed GmbH 39 European Marketing Authorizations 39 HYVISC R 39 AMEX IVX LSE IVX.L 39 Combidex 39 alogliptin NDA 39 outlicensed 39 histamine dihydrochloride 39 Rectogesic 39 practicable thereafter 39 further incensing Pyongyang 39 Cell Genesys stockholders 39 SURFAXIN 39 Receives Clearance 39 incorporate CXA 39 k clearance 39 molecular immunohematology products 39 Topiramate Tablets 39 TNRO 39 specify Alturas 39 compound CXA 39 Sabex Holdings Ltd. 39 Demerger Scheme 39 Aurvista 39 CryoSeal FS System 39 acquisition 39 MONOVISC 39 Operator Certificate 39 Oracea ® 39 Eucreas 39 Pennsaid Plus 39 Data Domain stockholders 39 Evoltra TM 39 daily Glumetza TM 39 Exelbine NDA 39 Chief Executive Ronald Brus 39 Severe hypersensitivity reactions 39 Neurobionix 39 Reloxin R 39 Combination Transaction 39 AMID Stapler TM 39 Stockholder Approval 39 Offeror intends 39 disinterested Shareholder approval 39 eSVS MESH 39 DIFICID ™ 39 Receives Stockholder Approval 39 Marketing Approval PMA 39 ISO certification 39 orphan designation 39 Nasdaq MYL 39 CardioMag 39 Discovery Informatics 39 Teflaro 39 Falconbridge Acquisition 39 Rasilez HCT 39 FDA approvable letter 39 pediatric exclusivity 39 Chaim Lebovits President 39 sumatriptan succinate tablets 39 Uplyso 39 attaching thereto 39 risksassociated 39 CLIA Waiver 39 Consent Time 39 HepaGam B 39 Cease Trade Orders 39 Valeant unsolicited 39 CCEA nod 39 CHMP recommendation 39 Gestiva ™ 39 SansRosa 39 Amitiza ® 39 infringed misappropriated invalid 39 EASA approvals 39 Telephone Replay Will 39 VBV 39 Preotact 39 incur unanticipated 39 APF# NDA 39 generic Copaxone 39 Virium 39 Ltd GCPL 39 Schweppes soft drinks 39 HepaGam B R 39 Amlodipine Besylate 39 CryoSeal 39 chemosaturation system 39 Amlodipine Besylate Tablets 39 Ranbaxy Laboratories Ltd. #.BY 39 Supplemental Type 39 anchor bottlers 39 Metricath Gemini 39 Oncobionic 39 ADSI reliance 39 becompleted 39 Nasdaq NPSP announced 39 ADSs tendered 39 Modrenal R 39 Vitaros R 39 suppliers hereby disclaim 39 certification 39 Brazil Ambev 39 crolibulin TM 39 Submits Biologics License Application 39 SILENOR ™ 39 LOPROX R 39 VistaPrint printed 39 NASDAQ IMDC 39 Norsemont Shares 39 Glenmark Generics Ltd 39 DRAXIS 39 ArPetrol Transaction 39 SonoPrep device 39 Exelbine 39 Administration TGA 39 regulatory approvals Introgen 39 GTC recombinant form 39 Market Authorization Application 39 Frontino Acquisition 39 Shonin approval 39 Cobalt Pharmaceuticals 39 hoFH 39 renamed Gavilon LLC 39 NitroMed stockholders 39 ASX CFE 39 liver resection surgeries 39 IND Investigational New 39 Application BLA 39 capture exosomes 39 subsidiaries visit http:/www.apricusbio.com 39 MDVIP collects 39 Regadenoson 39 News# editors 39 drug ISA# 39 Common Criteria validation 39 SYCREST 39 FIPS #-# certification 39 Bioral Amphotericin B 39 CholeraGarde R Peru 39 warrantholder approval 39 Adaptif Photonics 39 sNDAs 39 Emezine 39 Co BMY.N 38 affect Petroflow 38 transactions contemplated 38 Restricted Jurisdiction 38 Orathecin 38 biosurgical 38 Exelixis compounds 38 TSX VENTURE FWR announces 38 cMET inhibitor 38 Japanese Encephalitis Vaccine 38 #D#C# 38 Organon BioSciences 38 CNPCI 38 ZEGERID Chewable Tablets 38 Merck KGaA generics 38 AGA Medical stockholders 38 Caliper Driven 38 novel proprietary KL4 38 markets HP Acthar 38 Vantas 38 ISO# certification [001] 38 Acceptance Forms 38 commonstock 38 VANTAS 38 Environmental Clearance 38 irrevocable undertakings 38 mildly dilutive 38 authorization 38 filingswith 38 reincorporation merger 38 Peregrino field 38 pulls Darvon painkiller 38 Ceplene R 38 DigiFab TM 38 blood thinner prasugrel 38 BioZone 38 Company nanocrystalline materials 38 Drug Submission 38 Vibativ 38 CytoFab 38 compound CIP FENOFIBRATE 38 Gestiva 38 Concurrent Financing 38 Dynepo 38 exclusivities 38 BEMA Granisetron 38 Zeneus 38 ThromCat 38 TechTeam Global stockholders 38 Maharatna status 38 file Form #b 38 ZURICH AFX Novartis AG 38 CMDCAS 38 CEFF financings subject 38 Reverse Takeover 38 NeoLipid drug 38 Promus Element 38 Qualifying Transaction QT 38 Purifine ® PLC 38 Proxy Forms 38 ANDA filings 38 statementsregarding 38 QFB status 38 Akorn Strides 38 uncertaintiesthat 38 BioSante licensees 38 Junovan 38 Onglyza metformin combo 38 Certican 38 vii Cubist ability 38 ISO TS #:# certification 38 trading symbol GCKO 38 HydroFix ™ 38 Innovision Shareholders 38 Sertraline Hydrochloride Tablets 38 Submits Response 38 AnorMED 38 Makes Unsolicited Bid 38 Becomes Wholly Owned Subsidiary 38 EGRIFTA ™ 38 submitted supplemental Biologics 38 Definitive Agreement 38 party payor reimbursement 38 LCE Holdings 38 Accelerated Feasibility Study 38 Urokinase 38 Common Criteria Recognition 38 Zemiva TM 38 bottleshops operator Australian 38 Completes Previously Announced 38 Veronate R 38 ELIQUIS 38 symbol GEX 38 GTC NASDAQ GTCB 38 Enlarged Group 38 Movectro 38 commercialized DURECT 38 Fast Track Status 38 Hematide ™ peginesatide 38 TOCOSOL Camptothecin 38 iChem VELOCITY 38 Company Skouries Olympias 38 bln aud takeover 38 LU biscuit 38 Announce Early Termination 38 ColonSentry TM test 38 regardingthe 38 PDTI 38 Nabi HB R 38 NYSE Amex PTN 38 Ambulatory EHR certification 38 ability tosuccessfully 38 NetApp Data Domain 38 professional licensures 38 Kosan dependence 38 Fodosine TM 38 On2 stockholders 38 rival GlaxoSmithKline Cervarix 38 Vertex Pharma 38 affecting BEO Bancorp 38 NNL preferred 38 BiDil XR 38 Nasdaq HRLY 38 causeactual results 38 CAMPATH 38 dividends Annaly 38 minimally dilutive 38 adversely affect Linktone 38 consents 38 JUVISTA 38 Pikra Vena 38 Generx TM 38 Definitive Agreements 38 CIMZIA r 38 Orthovita filings 38 Rotarix ® 38 Binding Offer 38 Vavasi 38 additional cytogenetic abnormalities 38 zinc concentrates purchased 38 Amends Agreement 38 transaction 38 Orphan Drug designations 38 renamed Vodafone Essar 38 Vitaros ® 38 divestiture 38 CoTherix logo 38 Allscripts Eclipsys 38 THELIN 38 consummated 38 PTIL 38 acceptance 38 Current negative coggins 38 Zanaflex Capsules competition 38 Atheros Quarterly Report 38 Shire PLC SHP.LN 38 HCT Ps 38 Cefprozil 38 HepeX B 38 Gwenco 38 Aurobindo Pharma Ltd 38 JCI accreditation 38 Marksans Pharma 38 fwiggins@progress-index.com 38 http:/www.optimerpharma.com 38 Replagal 38 Barr ANDA 38 PTCRB 38 carcinogenicity studies 38 conditional inter alia 38 Clinical Trial Application 38 novel therapeutic modality 38 Biomerge 38 commercialization milestones 38 Marketing Authorization Application MAA 38 include ClindaReach TM 38 CallWave stockholders 38 Inc. Nasdaq SLXA 38 Conexant stockholders 38 developments affecting SIAF 38 Thalomid R 38 SuperStitch R 38 commercialize NicVAX 38 Thermadyne shareholders 38 due diligences 38 Famy Care 38 Phase IIa clinical trials 38 Taiho Pharmaceutical 38 Merger Regulation 38 BENLYSTA ® 38 theacquisition 38 ANVISA 38 Firdapse ™ amifampridine phosphate 38 BioGlue ® 38 GEM #S ® 38 Trintech Shareholders 38 requisite permissions 38 generic Valtrex 38 Bullabulling Gold Project 38 XIAPEX 38 Shareholders Approve Acquisition 38 Dermylex 38 Eliquis 38 Generex Oral lyn tm 38 French Autorite des 38 SSRM Holdings Inc. 38 Kibali Jersey 38 Dadri Bawana Nangal 38 Files Shelf Registration Statement 38 Contingent Value Right 37 Amend Merger Agreement 37 Oracea TM 37 Dynepo TM 37 HalcyGen 37 VV Mineral 37 Aly Participacoes Ltda 37 covenant waivers 37 Fortigel 37 Expiration Date 37 Copegus R 37 rapamycin derivatives 37 meaningfully accretive 37 Federated Kaufmann Funds 37 representations warranties covenants 37 Terminates Merger Agreement 37 Paramount Pictures Universal Studios 37 Preferential Allotment 37 Smucker Folgers 37 Orphan designation 37 Aclasta Reclast 37 Whitewash Waiver 37 notlimited 37 OFIRMEV 37 Optaflu 37 deploy MDCE services 37 AS# certification 37 Stockholders Approve Merger Agreement 37 Iluvien ® 37 NASDAQ CLZR 37 ViaCord R 37 DPX Survivac 37 Premarket Approval Application 37 Common Criteria CC 37 mini ratna status 37 Sanvar R 37 farmouts 37 differmaterially 37 Australian Therapeutic Goods 37 warrantholders 37 USFDA 37 IV acetaminophen 37 oral taxane 37 PGP Acquisition 37 EAL4 + certification 37 approvable letters 37 Entereg R 37 Generally Tamarkin 37 Lovaza TM 37 Antitrust Clearance 37 mesylate tablets approved 37 German drugmaker Ratiopharm 37 rolling Biologics License 37 Captisol ® 37 Fanapt ™ 37 miniratna status 37 Spain Iberia Lineas 37 Cefprozil tablets 37 directive Ionides 37 Retacrit 37 refinance indebtedness 37 GMP Certification 37 QAB# indacaterol 37 PolyHeme successfully 37 DSL.net s 37 Camp Caiman project 37 Algatec 37 Icoworks Holdings 37 Urocidin 37 Microcutter 37 Tolmar 37 Cephalon GlaxoSmithKline Organon 37 nondividend distribution 37 Vasovist 37 Reclast Aclasta 37 Centralized Procedure 37 Transkaryotic Therapies TKTX 37 NASDAQ PHRM 37 Orphan Status 37 WWD Subscription 37 Announce Successful Completion 37 NextView contract 37 Elitech 37 AI IA 37 Implex Corp. 37 Flutiform TM 37 Stockholders Approve Merger 37 Bellus Health 37 distributorship agreements 37 Definitive Proxy Statement 37 remaining untendered 37 Noncompetitive bids must 37 BioSTAR R 37 CompAir acquisition 37 ISO IEC #:# certification 37 cancellations rescheduling 37 Arigene 37 Valera Pharmaceuticals Inc. 37 Oryx Pharmaceuticals 37 GHL Acquisition stockholders 37 Tendered Notes 37 Reloxin 37 Michelago Limited 37 commercialize CorMedix drug 37 ISO# certifications [002] 37 IONSYS 37 TRUSTCASH 37 RAPIDGate Program contains 37 NYSE AMEX PLX 37 Clearant Process ® 37 Brilique 37 Impavido R 37 Laboratorios Rimafar 37 fundamentally undervalues 37 rStar 37 crinobulin 37 Mycograb 37 PBG PAS 37 GHIL 37 radiotherapy radiosurgery proton therapy 37 methods Spillars 37 Complete Response letter 37 Receives Tentative FDA 37 highly purified pasteurized 37 Stockholders Approve 37 Multiferon 37 Kaneb Partners 37 BioStem Inc. 37 HuMax TAC 37 romance happythankyoumoreplease written 37 PROLACRIA ™ 37 Announces Early Termination 37 Medigen 37 delisting proceedings 37 Morocco Meditel 37 nonexclusive licenses 37 optionholders 37 cohabiting heterosexual pairs 37 PentaLyte R 37 Onalta ™ 37 Solasia 37 AMPS Risk 37 ISO #:# Certification [002] 37 Tranzeo logo 37 Ceplene histamine dihydrochloride 37 PureGraft 37 Milestone Payment From 37 daily bactericidal antibiotic 37 ReNvision 37 Calixa 37 use authorization EUA 37 Receives Orphan Drug 37 Unsolicited Proposal From 37 cethromycin NDA 37 Decentralized Procedure 37 timelines communicated 37 Upon consummation 37 BrachySil 37 Preliminary Approval 37 Entereg TM 37 submit Biologics License 37 SILENOR 37 any biodefense procurement 37 successfully integrate Legerity 37 Progenta TM 37 Edwards Lifesciences AG 37 Prednisporin 37 Biologics Licensing 37 Surfaxin lucinactant 37 Sumatriptan Succinate 37 OMNARIS HFA 37 AXA APH minority 37 OraTest R 37 GA GCB 37 Fronteer Offer 37 Loramyc ® 37 acquisitions 37 Receives Fast Track 37 SolidCore 37 supplemental biologics 37 Avivo Corporation 37 Alantos 37 Eligard R 37 apaziquone 37 permits consents 37 Xechem Nigeria 37 withrespect 37 Irinotecan Hydrochloride Injection 37 MEZAVANT 37 Georox Resources Inc. 37 NETM 37 OmniComm intends 37 vaginal lidocaine 37 website www.activisionblizzard.com 37 AnorMED expectation 37 Willowstar 37 execute supplemental indenture 37 Bioaccelerate compounds under 37 Ceplene ® 37 Receives Marketing Authorization 37 AFSSAPS 37 Canetic Unitholders 37 MQ Associates 37 Granted Early Termination 37 NovaScreen Biosciences 37 Allovectin 7 37 Inc. NASDAQ BMET 37 Rexahn licensees 37 Nebido 37 Humanitarian Device Exemption 37 Drug Administration USFDA 37 iii GTx 37 largest bottlers Pepsi 37 Japanese MHLW 37 Exelon Patch 37 Note Movie showtimes 37 non waivable 37 Amalgamating Corporations 37 tender offer 37 CRINONE ® 37 Euro Ressources 37 Replete electrolytes 37 Gets Clearance 37 Offerors Commercial applies 37 Charles Revson Foundation 37 BioGlue R 37 Firazyr ® 37 Nexavar sorafenib tablets 37 IsoTis stockholders 37 SILENOR TM 37 CreXus 37 Pillar5 37 ASX EQN 37 EP MedSystems shareholders 37 acquiror 37 AVINZA ® 37 Frova ® 37 iVoice shareholders 37 vesting provisions 37 treats leashes collars 37 supplemental Biologics License Application 37 Ivax Teva 37 HeartWare System 37 commercialize ZYFLO CR 37 notifiable transaction 37 Angioblast 37 ZCI Offer 37 JITC certification 37 EHT AGN 37 OfficeScreen 37 Metformin Hydrochloride 37 Kobra Mining 37 Managing Director Asim Ghosh 37 Mikros primary 37 Fanandakis 37 GeoVax AIDS vaccine 37 ABthrax meets 37 ISO# certification [002] 37 Mayne Pharma Ltd. 37 Godrej Beverages 37 AZD Offer 37 divest 37 without limitation 37 assent 37 IMMUNITY FX 37 TheraCIM 37 corporate website http:/www.gamestopcorp.com 37 NASDAQ EPMD 37 FSRU conversions 37 Sular formulation 37 Superior Proposal 37 clean.Comments 37 NABH accreditation 37 certifications 37 Orbix R 37 cusip number